Stay up to date with the latest breaking news, analysis and commentary on Mirae Asset Sharekhan. Find live updates, exchanges, stock news, earning news and more.
Shilpa Biologicals Ltd, a material subsidiary of Shilpa Medicare Ltd announced the commissioning of a state-of-the-art Antibody–Drug Conjugate (ADC) GMP Manufacturing Facility, purpose-built and designed to meet global regulatory approval standards including US FDA, EMA, and other major health authority requirements. The facility is fully operational, with GMP qualification protocols now actively underway, placing Shilpa on a clear path to commercial readiness.
At 9.40 am, Shilpa Medicare Ltd was trading at Rs. 589.45, down by 0.19%, with a volume of 0.12 lakh shares on the BSE.
Investment of Rs. 1,500 crore committed for premium realty projects
25 Jun 2026, 1:33PMFloor price set at Rs 613.69 per equity share
25 Jun 2026, 1:11PML&T wins order for Power Transmission & Distribution Business in Saudi Arabia
29-10-2025 10:13:15The ePlane Company signs MOU with Ramco Systems
27-10-2025 12:42:39Refex Industries gets an order worth Rs. 300 Cr from a mining entity in Jharkhand
24-10-2025 13:57:18Diwali Stocks Picks 2025
